Neuland Laboratories Limited has informed the Exchange regarding 'Update on Outcome of Board meeting and Change in Directorate disclosures regarding appointment of additional director .Please note that there was a typographical error in the subject line under Disclosure B of the Outcome of Board Meeting intimated on July 31, 2025. It should be read as Appointment, instead of Reappointment, as under: B. Appointment of Dr. Ravi Shankar Gopinath (DIN: 00803847) as an Additional Director of the Company